Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.
about
Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature ReviewLoco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapyTreatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive reviewSorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studiesTransarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patientsHepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma MeetingAdvanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-upRecent advances in multidisciplinary management of hepatocellular carcinomaComparison of hepatocellular carcinoma in Eastern versus Western populations.Management strategies for hepatocellular carcinoma: old certainties and new realities.Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.Radioembolization of hepatic tumorsMinimally invasive local therapies for liver cancerHepatocellular carcinoma: clinical frontiers and perspectives.Locally ablative therapies for primary and metastatic liver cancer.Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.Liver cancer: Approaching a personalized care.Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts.Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.Nonsurgical treatment for localized hepatocellular carcinoma.Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantationBaseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancerTrans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses.Hepatocellular carcinoma review: current treatment, and evidence-based medicine.Evidence-based integration of selective internal radiation therapy into hepatocellular carcinoma management.Liver function considerations for post-selective internal radiation therapy resection (hepatocellular carcinoma and metastatic colorectal cancer).Bridging and downstaging to transplantation in hepatocellular carcinoma.Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.A descriptive analysis of remnant activity during (90)Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implications.Locoregional and systemic therapy for hepatocellular carcinoma.Advances in Local and Systemic Therapies for Hepatocellular Cancer.Systemic treatment for advanced hepatocellular carcinoma: the search of new agents to join sorafenib in the effective therapeutic armamentarium.Multifunctional microbeads for drug delivery in TACE.New Approaches in Locoregional Therapies for Hepatocellular Carcinoma.Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients: A systematic review and meta-analysis.Efficacy of radioembolization according to tumor morphology and portal vein thrombosis in intermediate-advanced hepatocellular carcinoma.Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma.Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.Transarterial Chemoembolization and Radioembolization across Barcelona Clinic Liver Cancer Stages.Hepatic artery and biliary complications in liver transplant recipients with radioembolization bridging treatment for hepatocellular carcinoma.
P2860
Q26743603-781C3AF9-E935-4574-8E2A-B358D0F08CE4Q26745962-554A6305-9903-410E-968D-2BC49D2B5753Q26772299-5381285C-8B4C-43C2-A1DC-968805693398Q26777892-82BA4DD4-5104-4F72-B233-1572B55693EFQ26799469-9C08B829-F32A-4FF1-8BBA-69CAF0E2FC38Q26828407-5C704ECA-3B0F-4EE3-A189-2313998B8504Q26851033-2BF20DF5-EED1-4CB9-9EE9-2718CBBB653CQ26863748-BAA880FF-C24A-425D-BC1D-32F6A3A23E4BQ30245396-FA6EE0CF-12DA-41FF-926D-646422A4F66CQ30252143-DCF721B4-C9E5-4086-859E-C7AD2F143CBFQ30276330-7C057AC3-1867-4C51-9D13-E0313B8DB42FQ33820777-1D2B56AD-78F1-4DEB-8126-E732B702E636Q34974386-3AA35F09-312D-49EA-817E-00FACF96451EQ35112053-F49D9293-2032-408A-B35F-7FBAA8F2473BQ35152457-E7C68838-EF41-49B1-B0F6-0921C8FE75F7Q35570801-507DD236-C2F2-44B9-83F4-E6F2FF29B8D4Q35903794-38E4F1FA-8B43-4A4B-B6C1-E161D8BCB48CQ36268905-DFFD068A-7265-4BC9-8FDA-8140EAB8C880Q37396794-67CF801F-7194-4FE9-BDDD-F7ED0B3B84BCQ37578521-129F3AA1-9DEB-49A3-BD1E-CD7D2FA1389EQ37675079-51222132-F2FE-4E66-9027-19541CB2A4ACQ37677524-C4664BDA-43EE-4462-A0AB-CC20D36906CCQ37687824-E43F286A-D48B-4CCA-9D82-2232B2A30648Q38207012-A2C16112-9024-4F20-A7CE-638D2BA5EE37Q38283651-13D5F36B-A8D9-481F-89BD-1EF20DE0E3BAQ38283670-8C8BFE4F-3CE7-4F85-BEAB-9660A0E40CDDQ38283671-6532E488-9BC0-4D41-AD80-B24EBABCB7BBQ38538075-A255185C-3645-4B2A-8E55-B863AB196055Q38675831-FAF1E009-C6E1-46F5-8010-A7536AB58BFFQ38686790-5670C14F-A73D-471F-8677-B272929E12E5Q38697243-C8352567-36C1-41D0-A4E7-9C4D899E7771Q38824017-4F43CAE2-A9E2-4BEE-AA78-20C33F5E3946Q38843998-C3DAB348-C432-4BA9-9E0A-8FEA3E04C114Q38857630-E51A2F56-C590-46FA-8FAC-81526CD7E987Q38883028-4821F00D-65AA-45D2-BBCB-BAD437806AA7Q38953448-FBBC6174-17BB-41BF-B1A0-1A857A348641Q38968638-CB0FCB8B-3D8B-4ECF-BDB9-79015104F8D4Q39067623-08DEC699-5DF1-44C6-B2F6-7771D6EB8108Q39349638-AF889CD0-4866-4498-AD22-E3A0C57D5A73Q40072454-EE6AF257-F458-41A1-AB78-1E76745D410E
P2860
Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Yttrium 90 radioembolization f ...... es, and clinical perspectives.
@en
Yttrium 90 radioembolization f ...... es, and clinical perspectives.
@nl
type
label
Yttrium 90 radioembolization f ...... es, and clinical perspectives.
@en
Yttrium 90 radioembolization f ...... es, and clinical perspectives.
@nl
prefLabel
Yttrium 90 radioembolization f ...... es, and clinical perspectives.
@en
Yttrium 90 radioembolization f ...... es, and clinical perspectives.
@nl
P2860
P50
P356
P1433
P1476
Yttrium 90 radioembolization f ...... es, and clinical perspectives.
@en
P2860
P304
P356
10.1002/HEP.26382
P407
P577
2013-10-04T00:00:00Z